Journey Medical Corp financial data

Symbol
DERM on Nasdaq
Location
Scottsdale, AZ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 135% % 2%
Quick Ratio 33% % 16%
Debt-to-equity 282% % -28%
Return On Equity -40% % 70%
Return On Assets -10% % 61%
Operating Margin -24% % -831%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $50,127,341 USD 309%
Weighted Average Number of Shares Outstanding, Basic 24,959,114 shares 22%
Weighted Average Number of Shares Outstanding, Diluted 24,959,114 shares 22%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $17,631,000 USD 21%
Revenue from Contract with Customer, Excluding Assessed Tax $57,793,000 USD 0.04%
Cost of Revenue $20,879,000 USD -8.8%
Research and Development Expense $287,000 USD -66%
Costs and Expenses $64,894,000 USD -14%
Operating Income (Loss) $5,495,000 USD 69%
Nonoperating Income (Expense) $3,047,000 USD -1463%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8,542,000 USD 53%
Income Tax Expense (Benefit) $60,000 USD
Net Income (Loss) Attributable to Parent $8,663,000 USD 53%
Earnings Per Share, Basic 0 USD/shares 64%
Earnings Per Share, Diluted 0 USD/shares 59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $24,948,000 USD 11%
Accounts Receivable, after Allowance for Credit Loss, Current $17,983,000 USD 69%
Inventory, Net $11,818,000 USD 0.25%
Assets, Current $56,387,000 USD 22%
Operating Lease, Right-of-Use Asset $134,000 USD 319%
Intangible Assets, Net (Excluding Goodwill) $28,670,000 USD 61%
Other Assets, Noncurrent $6,000 USD 0%
Assets $85,191,000 USD 33%
Accounts Payable, Current $11,557,000 USD -25%
Accrued Liabilities, Current $21,193,000 USD 32%
Liabilities, Current $39,715,000 USD 19%
Operating Lease, Liability, Noncurrent $44,000 USD
Liabilities $59,293,000 USD 12%
Retained Earnings (Accumulated Deficit) $97,211,000 USD -9.8%
Stockholders' Equity Attributable to Parent $25,898,000 USD 137%
Liabilities and Equity $85,191,000 USD 33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,832,000 USD 44%
Net Cash Provided by (Used in) Financing Activities $3,597,000 USD 120%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $765,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24,948,000 USD 11%
Interest Paid, Excluding Capitalized Interest, Operating Activities $813,000 USD 204%
Deferred Tax Assets, Valuation Allowance $24,043,000 USD 19%
Deferred Tax Assets, Gross $24,093,000 USD 19%
Operating Lease, Liability $142,000 USD 318%
Lessee, Operating Lease, Liability, to be Paid $149,000 USD 338%
Operating Lease, Liability, Current $98,000 USD 188%
Lessee, Operating Lease, Liability, to be Paid, Year Two $18,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $105,000 USD 1067%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $18,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $6,814,000 USD 56%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $123,106,000 USD 24%
Amortization of Intangible Assets $4,175,000 USD 31%
Deferred Tax Assets, Net of Valuation Allowance $50,000 USD 100%
Share-based Payment Arrangement, Expense $5,891,000 USD 12%
Interest Expense $1,596,000 USD -30%